title: Molecular Pathology of the Genitourinary Tract: Prostate and Bladder.
abstract: The knowledge of cellular mechanisms in tumors of the prostate and bladder has grown exponentially. Molecular technologies have led to the discovery of TMPRSS2 in prostate cancer and the molecular pathways distinguishing low- and high-grade urothelial neoplasms. UroVysion with fluorescence in situ hybridization is already commonplace as an adjunct to cytologic diagnosis of urothelial neoplasms. This trend portends the future in which classification and diagnosis of tumors of the prostate and bladder through morphologic analysis will be supplemented by molecular information correlating with prognosis and targeted therapy. This article outlines tumor molecular pathology of the prostate and bladder encompassing current genomic, epigenomic, and proteonomic findings.
authors.affiliation: Pathology Informatics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
authors.forename: S Joseph
authors.initials: SJ
authors.lastname: Sirintrapun
authors.affiliation: Department of Pathology, University of Pittsburgh Medical Center Shadyside Hospital, Room WG 07, 5230 Centre Avenue, Pittsburgh, PA 15232, USA. Electronic address: parwaniav@upmc.edu.
authors.forename: Anil V
authors.initials: AV
authors.lastname: Parwani
keywords: FISH; Genomics; Molecular pathology; Molecular techniques; Prostate; Urinary bladder